R

Retina Centre of Ottawa | Ottawa, Canada

Research site

(Unclaimed)

Location

2211 Carling Avenue, Ottawa, Ontario, Canada

Site insights

Top conditions

Top treatments

APL-2

Dexamethasone

Ranibizumab

Zimura

ANX007

Pegcetacoplan

Avacincaptad pegol

IBE-814

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 9 total trials

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy (SIENNA)

This study is researching experimental (study) drugs called pozelimab and cemdisiran. The study is focused on participants who have Geographic Atroph...

Enrolling

Age-related Macular Degeneration (AMD)

Geographic Atrophy (GA)

Drug: Placebo

Drug: Pozelimab

A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA) (ARCHER II)

The primary purpose of the study is to determine if IVT injections of vonaprument every month reduce vision loss in participants with dry AMD with GA.

Active, not recruiting

Geographic Atrophy

Drug: Vonaprument

Other: Sham Administration

Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD (ASCENT)

ABBV-RGX-314 (also known as RGX-314 and surabgene lomparvovec (sura-vec)) is being developed as a novel one-time gene therapy for the treatment of ne...

Enrolling

Wet Age-related Macular Degeneration

WetAMD

Genetic: ABBV-RGX-314 Dose 1

Biological: Aflibercept (EYLEA®)

Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)

Neovascular age-related macular degeneration (nAMD), also known as "wet" AMD, is the abnormal growth of new blood vessels in the light-sensitive tiss...

Enrolling

Neovascular Age-related Macular Degeneration

Drug: Surabgene Lomparvovec (ABBV-RGX-314)

Drug: Ranibizumab Control